BigBear.ai Holdings, Inc. (NYSE: BBAI), a U.S.-based artificial intelligence and analytics firm specializing in defense and logistics applications, is reportedly preparing a secondary equity...
Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a clinical-stage biotech company specializing in peptide-based therapeutics, is reportedly planning a follow-on public offering to fund late-stage clinical...
Hong Kong-based asset management firm Keystone Global Financial Group Ltd. has filed and set terms for a $6 million initial public offering (IPO) in...
Grupo Financiero Galicia S.A. (NASDAQ: GGAL), one of Argentina’s leading financial institutions, is reportedly exploring a new equity issuance to strengthen its capital position...
Intellia Therapeutics, Inc. (NASDAQ: NTLA), a clinical-stage biotechnology leader in CRISPR-based gene editing, continues to attract investor attention amid growing expectations for the next...